PLEASANTON, Calif., July 25, 2012 /PRNewswire/ -- Safeway Inc. (NYSE: SWY) today announced that its month-long Prostate Cancer Awareness Campaign raised over $9 million to help find new treatments and an ultimate cure for prostate cancer.
"We are infinitely grateful for all of the customer and community support for a campaign that will help save the lives of countless men worldwide," said Larree Renda, Safeway Executive Vice President and Chair of the Safeway Foundation. "Prostate cancer is the number one cancer killer of men. These contributions, one dollar at a time, are sparing lives by funding critical research and the absolute best treatment at the most renowned cancer centers in North America."
This is the 12th year that Safeway, one of the largest corporate supporters of cancer research, has dedicated the entire month of June to raising funds at its stores, production facilities and corporate offices for prostate cancer research. The company works with the Prostate Cancer Foundation to identify and provide grants for promising research. The outcomes of the nearly 1,600 Safeway-funded research projects include the identification of more than 27 cancer-causing gene fusions, new biomarkers for diagnosis and treatment response assessment and the development of new drugs to deliver more effective treatments for patients with advanced stages of the disease. The death rate has dropped roughly 40 percent in the U.S. alone, meaning nearly 200,000 American men are alive today because of improved treatment.
"The partnership with Safeway, its customers and employees has been nothing short of amazing," said Jonathan Simons, MD, President and CEO of the Prostate Cancer Foundation. "Advancements made possible by these donations are paving the way for better methods to diagnose and treat patients battling the disease."
The 2012 Prostate Cancer Awar
|SOURCE Safeway Inc.|
Copyright©2012 PR Newswire.
All rights reserved